Skip to main content
. 2023 Mar 8;28(6):2475. doi: 10.3390/molecules28062475

Figure 2.

Figure 2

Cell viability in HepG2 cells untreated (Ctr), HepG2 cells treated for 12 h with 1.5 mM FFAs 1, and HepG2 cells pre-treated with the extract (10–25–50μg/mL) and exposed to FFAs 1. Values are the mean ± S.D. of three independent experiments in triplicate. * Significant vs. untreated control cells: p < 0.001. # Significant vs. FFAs treated cells: p < 0.001.